Chinese Journal of Tissue Engineering Research ›› 2021, Vol. 25 ›› Issue (11): 1745-1752.doi: 10.3969/j.issn.2095-4344.3090
Previous Articles Next Articles
Tian Yanping, Li Juan, Liu Xiaobo, Zhang Huiling, Shi Lihong, Jin Rongjiang
Received:
2020-03-24
Revised:
2020-03-30
Accepted:
2020-05-09
Online:
2021-04-18
Published:
2020-12-22
Contact:
Jin Rongjiang, MD, Professor, Doctoral supervisor, School of Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan Province, China
About author:
Tian Yanping, Master candidate, School of Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan Province, China
Supported by:
CLC Number:
Tian Yanping, Li Juan, Liu Xiaobo, Zhang Huiling, Shi Lihong, Jin Rongjiang. Knowledge network mapping of literature regarding platelet-rich plasma in recent 5 years: a visual analysis[J]. Chinese Journal of Tissue Engineering Research, 2021, 25(11): 1745-1752.
2.2 国家/地区和机构分布 2.2.1 国家/地区 运行CiteSpace软件,以国家为节点,得到的富血小板血浆研究领域国家分布图谱中,共有64个节点,400条连线,显示了国家/地区合作网络关系,见图2。图谱中圆圈表示国家/地区,圆圈越大表示国家/地区合作发文量越多。含有深色外圈的国家/地区代表与其他国家/地区的合作很重要。分析可知合作发文量较多的国家为美国、中国、意大利和西班牙,其中美国和多个国家/地区的合作关系都较为密切,中国与美国、德国、英国等欧美国家有合作关系。中心性代表着国家研究的重要性与国家间合作的紧密性。美国的中心性最大为0.22,其次是德国和英国,中心性分别为0.18,0.16。由此可知,美国在富血小板血浆研究中处于重要的地位。中国的发文量虽位列第二,但是中国的中心性较小为0.01,说明中国发文量较大,但影响力却不足。 "
2.2.2 机构 以机构为节点对相关文献记录进行分析,得到节点数为68,连线数为22的国内发文机构图谱,见图3。图3显示的是发文量≥3篇的机构,其中发文量前三的是上海交通大学附属第六人民医院骨科(7篇)、广州军区广州总医院输血科(5篇)、广州中医药大学(4篇),但各个机构的中心性均较低,机构之间较为分散,各机构之间的合作交流少。同样地,运行CiteSpace软件,以机构为节点,得到节点数为228,连线数为534的国外发文机构网络图谱,见图4。其中发文量前五的机构分别是美国纽约特种外科医院(85篇)、美国拉什大学(57篇)、美国匹兹堡大学(55篇)、意大利米兰大学(55篇)、中国上海交通大学(50篇)。中心性排名前五的机构为意大利米兰大学(0.24)、美国匹兹堡大学(0.21)、美国斯坦福大学(0.20)、美国拉什大学(0.20)、德黑兰大学(0.15)。结果显示,美国机构不管在发文的数量上还是在发文的影响力上都处于领先水平并且重视与其他机构之间的交流合作。 "
2.3 作者分布及合作情况 以作者为节点对相关文献记录进行分析,得到的知识图谱分别见图5,6。图中的节点大小表示作者的发文量,连线代表作者间的联系或合作关系。图5节点数为267,连线数为372。学者单桂秋、袁霆、张长青的发文频次较高分别是10,6,6。但是,国内缺乏中心性较高的作者。图6中节点数为359,连线数为628。作者Anitua E,Orive G,Cole BJ的发文频次较高分别为65,45,34。中心性前三的作者为Laprade RF,Filardo G,Chahla J。以上6位作者中有两位来自西班牙,3位来自美国,1位来自意大利。从图4可以看出各作者之间联系较为紧密,尤其在高产作者与中心性较高的作者之间。 "
2.4 研究热点 2.4.1 关键词共现分析 以关键词为节点对其进行共现分析,选择Pathfinder进行剪切,运行CiteSpace软件得到图7,8。在中文文献图谱中共有176个节点,370条连线,见图7。图中十字架越大,表示该关键词的共现频次最高。可以看出,除去与检索策略相关的主题词。共现频次由高到低依骨关节炎47次、生长因子41次、组织工程30次、股骨头坏死28次、富血小板纤维蛋白26次。关键词共现中心性由高到低依次是骨髓间充质干细胞0.24、玻璃酸钠0.23、组织工程0.20、骨不连0.19、生长因子0.16。根据以上关键词的共现频次及中心性可知,国内较为热点的关键词为生长因子、骨髓间充质干细胞、骨关节炎等。外文文献图谱中共有96个节点,233条连接线,见图8。共现频次由高到低依次是生长因子(growth factor)947次、间充质干细胞(mesenchymal stem cell)596次、干细胞(stem cell)461次、双盲(double blind)408次、体外(in vitro)381次。关键词共现中心性由高到低依次是修复(repair)0.41、白细胞(leukocyte)0.25、间充质干细胞(mesenchymal stem cell)0.24、肌腱病(tendinopathy)0.22、透明质酸(hyaluronic acid)0.2。根据以上内容综合分析可知,国际上此领域的热点关键词为生长因子、间充质干细胞和修复等。 "
2.6 被引期刊 由于CiteSpace无法实现对中文文献进行被引期刊分析,所以仅分析英文期刊的被引情况。以检索到的WOS文献记录为基础,选择节点为被引期刊运行CiteSpace软件,得到节点74连线131的知识网络图谱见图14。其中,被引频次前三的期刊依次为《AM J SPORT MED》(1 931)、《J BONE JOINT SURG AM》(1 563)、《ARTHROSCOPY》(1 430);中心性前三的期刊依次为:《BIOMATERIALS》(0.79)、《J ORTHOP RES》(0.69)、《CLIN ORAL IMPLAN RES》(0.44)。以上6所期刊中,5所来自美国,1所来自荷兰。其中《American Journal of Sports Medicine》期刊的被引频次最高,荷兰《Biomaterials》期刊中心性最高。 "
[1] PATEL S, DHILLON MS, AGGARWAL S, et al. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013; 41(2):356-364. [2] GENTILE P, SCIOLI MG, BIELLI A, et al. Concise Review: The Use of Adipose-Derived Stromal Vascular Fraction Cells and Platelet Rich Plasma in Regenerative Plastic Surgery. Stem Cells.2017;35(1):117-134. [3] MARTINEZZAPATA MJ, MARTICARVAJAL AJ, SOLA I, et al. Autologous platelet-rich plasma for treating chronic wounds.Cochrane Database Syst Rev.2016;(5):D6899. [4] CARUANA A, SAVINA D, MACEDO JP, et al. From Platelet-Rich Plasma to Advanced Platelet-Rich Fibrin: Biological Achievements and Clinical Advances in Modern Surgery. Eur J Dent. 2019;13(2):280-286. [5] 李杰,陈超美.citespace科技文本挖掘及可视化[M].北京:北京首都经济贸易大学出版社有限责任公司,2016. [6] 陈悦,陈超美,刘则渊,等. CiteSpace知识图谱的方法论功能[J].科学学研究,2015, 33(2): 242-253. [7] 赵建保. CiteSpace可视化流程与分析范式研究[J]. 知识经济, 2014(16):105-107. [8] 赵丹群. 基于CiteSpace的科学知识图谱绘制若干问题探讨[J].情报理论与实践,2012,35(10):56-58. [9] FOSTER TE, PUSKAS BL, MANDELBAUM BR, et al. Platelet-rich plasma: from basic science to clinical applications.Am J Sports Med. 2009;37(11):2259-2272. [10] KON E, MANDELBAUM B, BUDA R, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011;27(11):1490-1501. [11] AMABLE PR, CARIAS RB, TEIXEIRA MV, et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013;4(3):67. [12] DELONG JM, RUSSELL RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. 2012;28(7):998-1009. [13] KROGH TP, FREDBERG U, STENGAARDPEDERSEN K, et al. Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial.Am J Sports Med. 2013;41(3):625-635. [14] MCCARREL TM, MINAS T, FORTIER LA. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy.J Bone Joint Surg Am. 2012;94(19):e141-e143. [15] DRAGOOJL, WASTERLAIN AS, BRAUN HJ, et al. Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial.Am J Sports Med. 2014;42(3):610-618. [16] ARIRACHAKARAN A, SUKTHUAYAT A, SISAYANARANE T, et al. Platelet-rich plasma versus autologous blood versus steroid injection in lateral epicondylitis: systematic review and network meta-analysis. J Orthop Traumatol. 2016;17(2):101-112. [17] SANCHEZAVILA RM, MERAYOLLOVES J, FERNANDEZ ML, et al. Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma.Int Med Case Rep J. 2018; 1197-1103. [18] SANCHEZAVILA RM, MERAYOLLOVES J, RIESTRA AC, et al. Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops.Int Ophthalmol. 2018;38(3): 1193-1204. [19] SANCHEZAVILA RM, MERAYOLLOVES J, RIESTRA AC, et al. The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjogren Syndrome. J Ocul Pharmacol Ther. 2017;33(5): 391-399. [20] SANCHEZ M, ANITUA E, DELGADO D, et al. A new strategy to tackle severe knee osteoarthritis: Combination of intra-articular and intraosseous injections of Platelet Rich Plasma.Expert Opin Biol Ther. 2016;16(5):627-643. [21] SANCHEZ M, FIZ N, GUADILLA J, et al. Intraosseous infiltration of platelet-rich plasma for severe knee osteoarthritis.Arthrosc Tech. 2014;3(6):e713-e717. [22] SCOTTA A, LAPRADE RF, HARMON KG, et al. Platelet-Rich Plasma for Patellar Tendinopathy: A Randomized Controlled Trial of Leukocyte-Rich PRP or Leukocyte-Poor PRP Versus Saline. Am J Sports Med. 2019;47(7):1654-1661. [23] FILARDO G, DI MATTEO B, KON E, et al. Platelet-rich plasma in tendon-related disorders: results and indications. Knee Surg Sports Traumatol Arthrosc. 2018;26(7):1984-1999. [24] ORYAN A, ALIDADI S, MOSHIRI A. Platelet-rich plasma for bone healing and regeneration. Expert Opin Biol Ther. 2016;16(2):213-232. [25] ORYAN A, ALIDADI S, MOSHIRI A, et al. Bone regenerative medicine: classic options, novel strategies, and future directions.J Orthop Surg Res. 2014;9(1):18. [26] MOSHIRI A, ORYAN A, MEIMANDIPARIZI A. Synthesis, development, characterization and effectiveness of bovine pure platelet gel-collagen-polydioxanone bioactive graft on tendon healing. J Cell Mol Med. 2015;19(6):1308-1332. [27] MALHOTRA A, PELLETIER MH, YU Y, et al. Can platelet-rich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes. Arch Orthop Trauma Surg. 2013;133(2):153-165. [28] CROSS JA, COLE BJ, SPATNY KP, et al. Leukocyte-Reduced Platelet-Rich Plasma Normalizes Matrix Metabolism in Torn Human Rotator Cuff Tendons. Am J Sports Med. 2015;43(12):2898-2906. [29] DAVIS VL, ABUKABDA AB, RADIO NM, et al. Platelet-rich preparations to improve healing. Part II: platelet activation and enrichment, leukocyte inclusion, and other selection criteria. J Oral Implantol. 2014;40(4): 511-521. [30] HESKETH M, SAHIN KB, WEST ZE, et al. Macrophage Phenotypes Regulate Scar Formation and Chronic Wound Healing. Int J Mol Sci. 2017;18(7):1545. [31] LIU W, CHEN B, ZHENG YY, et al. Effect of platelet-rich plasma on implant bone defects in rabbits through the FAK/PI3K/AKT signaling pathway. Open Life Sciences. 2019;14(1):311-317 [32] HOEFERLIN LA, HUYNH QK, MIETLA JA, et al. The Lipid Portion of Activated Platelet-Rich Plasma Significantly Contributes to Its Wound Healing Properties. Adv Wound Care (New Rochelle). 2015;4(2): 100-109. [33] LEE HW, CHOI KH, KIM JY, et al. Proteomic Classification and Identification of Proteins Related to Tissue Healing of Platelet-Rich Plasma. Clin Orthop Surg. 2020;12(1):120-129. [34] ZHANG C, ZHU Y, LU S, et al. Platelet-Rich Plasma with Endothelial Progenitor Cells Accelerates Diabetic Wound Healing in Rats by Upregulating the Notch1 Signaling Pathway. J Diabetes Res. 2019; 20195920676. [35] ZHANG L, ZHANG B, LIAO B, et al. Platelet-rich plasma in combination with adipose-derived stem cells promotes skin wound healing through activating Rho GTPase-mediated signaling pathway. Am J Transl Res. 2019;11(7): 4100-4112. [36] CHIGNONSICARD B, KOUIDHI M, YAO X, et al. Platelet-rich plasma respectively reduces and promotes adipogenic and myofibroblastic differentiation of human adipose-derived stromal cells via the TGFbeta signalling pathway. Sci Rep. 2017;7(1):2954. [37] COLE BJ, KARAS V, HUSSEY K, et al. Hyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-articular Biology for the Treatment of Knee Osteoarthritis. Am J Sports Med. 2017;45(2):339-346. [38] HURLEY ET, LIM FAT D, MORAN CJ, et al. The Efficacy of Platelet-Rich Plasma and Platelet-Rich Fibrin in Arthroscopic Rotator Cuff Repair: A Meta-analysis of Randomized Controlled Trials. Am J Sports Med. 2019;47(3): 753-761. [39] SMITH PA. Intra-articular Autologous Conditioned Plasma Injections Provide Safe and Efficacious Treatment for Knee Osteoarthritis: An FDA-Sanctioned, Randomized, Double-blind, Placebo-controlled Clinical Trial.Am J Sports Med. 2016;44(4):884-891. |
[1] | Zhu Xuefen, Huang Cheng, Ding Jian, Dai Yongping, Liu Yuanbing, Le Lixiang, Wang Liangliang, Yang Jiandong. Mechanism of bone marrow mesenchymal stem cells differentiation into functional neurons induced by glial cell line derived neurotrophic factor [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(7): 1019-1025. |
[2] | Wang Zhengdong, Huang Na, Chen Jingxian, Zheng Zuobing, Hu Xinyu, Li Mei, Su Xiao, Su Xuesen, Yan Nan. Inhibitory effects of sodium butyrate on microglial activation and expression of inflammatory factors induced by fluorosis [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(7): 1075-1080. |
[3] | Jiao Hui, Zhang Yining, Song Yuqing, Lin Yu, Wang Xiuli. Advances in research and application of breast cancer organoids [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(7): 1122-1128. |
[4] | Huang Dengcheng, Wang Zhike, Cao Xuewei. Intravenous, topical tranexamic acid alone or their combination in total knee arthroplasty: a meta-analysis of randomized controlled trials [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(6): 948-956. |
[5] | Zhan Fangbiao, Cheng Jun, Zou Xinsen, Long Jie, Xie Lizhong, Deng Qianrong. Intraoperative intravenous application of tranexamic acid reduces perioperative bleeding in multilevel posterior spinal surgery: a meta-analysis [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(6): 977-984. |
[6] | Yang Xin, Jin Zhe, Feng Xu, Lu Bing. The current situation of knowledge and attitudes towards organ, eye tissue, body donation of residents in Shenyang [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(5): 779-784. |
[7] | Zhang Guomei, Zhu Jun, Hu Yang, Jiao Hongwei. Stress of three-dimensional finite element models of E-MAX porcelain inlay [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(4): 537-541. |
[8] | Liu Fei, Cui Yutao, Liu He. Advantages and problems of local antibiotic delivery system in the treatment of osteomyelitis [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(4): 614-620. |
[9] | Ye Haimin, Ding Linghua, Kong Weihao, Huang Zutai, Xiong Long. Role and mechanism of hierarchical microchanneled bone scaffolds in promoting osteogenesis and angiogenesis [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(4): 621-625. |
[10] | Yu Langbo, Qing Mingsong, Zhao Chuntao, Peng Jiachen. Hot issues in clinical application of dynamic contrast-enhanced magnetic resonance imaging in orthopedics [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(3): 449-455. |
[11] | Huang Maomao, Hu Yue, Wang Binchuan, Zhang Chi, Xie Yujie, Wang Jianxiong, Wang Li, Xu Fangyuan. Bibliometric and visual analysis of international literature addressing ischemic stroke rehabilitation in recent 10 years [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(23): 3725-3733. |
[12] | Zhu Rui, Zeng Qing, Huang Guozhi. Ferroptosis and stroke [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(23): 3734-3739. |
[13] | Li Shanshan, You Ran, Guo Xiaoxiao, Zhao Lu, Wang Yanling, Chen Xi. Advances in the mechanisms of optic nerve regeneration [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(23): 3740-3745. |
[14] | Wang Zhen, Lin Haiqi, He Fei, Lin Wentao. Exercise activates skeletal muscle satellite cells: exercise prevention and treatment for age-related sarcopenia and muscle injury [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(23): 3752-3759. |
[15] | Song Shilei, Chen Yueping, Zhang Xiaoyun, Li Shibin, Lai Yu, Zhou Yi. Potential molecular mechanism of Wuling powder in treating osteoarthritis based on network pharmacology and molecular docking [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(20): 3185-3193. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||